These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21256788)

  • 1. [Physical compatibility of sodium bicarbonate with other drugs often administered in the intensive care unit].
    Ribas Nicolau B; Pérez Juan E; Amorós Cerdá SM; Arévalo Rubert MJ; Maqueda Palau M
    Enferm Intensiva; 2011; 22(2):78-82. PubMed ID: 21256788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].
    Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM
    Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a dual-lumen peripheral catheter on the delivery of known incompatible medications.
    Prince RA; Lucas DS; Fox JL
    Ann Pharmacother; 1998 Sep; 32(9):875-7. PubMed ID: 9762372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
    Koller AK; Krebs S; Dörje F
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability studies of binary mixtures of haloperidol and/or midazolam with other drugs for parenteral administration.
    Gómez MA; Arenas VJ; Sanjuán MM; Hernández MJ; Almenar CB; Torres VJ
    J Palliat Med; 2007 Dec; 10(6):1306-11. PubMed ID: 18095809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incompatibility of the short-acting benzodiazepine remimazolam with common perioperative medication.
    Hofmann P; Bachmann L; Brümmer P; Drexler B
    BMC Anesthesiol; 2024 Jul; 24(1):233. PubMed ID: 38992570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sodium bicarbonate, disodium carbonate, and a sodium bicarbonate/carbonate mixture on the PCO2 of blood in a closed system.
    Shapiro JI; Elkins N; Logan J; Ferstenberg LB; Repine JE
    J Lab Clin Med; 1995 Jul; 126(1):65-9. PubMed ID: 7602236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.
    Moriyama B; Henning SA; Jin H; Kolf M; Rehak NN; Danner RL; Walsh TJ; Grimes GJ
    Am J Health Syst Pharm; 2010 Apr; 67(7):562-5. PubMed ID: 20237384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of medications during multi-infusion therapy: A controlled in vitro study on a multilumen infusion device.
    Perez M; Décaudin B; Foinard A; Barthélémy C; Debaene B; Lebuffe G; Odou P
    Anaesth Crit Care Pain Med; 2015 Apr; 34(2):83-8. PubMed ID: 25858619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administrating incompatible drugs by a retrograde intravenous infusion system.
    Johnson CE; Roesner MP; Berman JR; Burch KJ
    Am J Hosp Pharm; 1985 Jan; 42(1):109-11. PubMed ID: 2982257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
    Correard F; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Aug; 71(15):1288-91. PubMed ID: 25027536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.